Tag Archives: Drug

Yale study shows drug increases survival for bladder cancer patients

By Anne Doerr There are no approved treatment options for patients with advanced bladder cancer after they’ve received standard chemotherapy and immune treatments, but the results of a phase II clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers demonstrate an effective treatment for this deadly disease. The findings were presented today at the… Read More »

Precision medicine as a way to improve oncology care — and potentially drive down drug costs

Broadly defined, precision medicine is about the personalization of care. Yet on a practical level, precision medicine can take on different forms in different subspecialties in healthcare. In modern oncology care, it’s largely about getting the right drugs to the right patient at the right time. There’s also some early evidence that more efficient targeted… Read More »

Lilly’s new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

INDIANAPOLIS (Reuters) – Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new class of migraine drugs, and seeks to build on that advantage by stressing that its therapy can completely prevent headaches in a small percentage of patients.… Read More »

Cutting US drug prices to match rates in other countries could save $73 billion on medicare

Cutting US drug prices to match rates in the UK, Japan and Canada would save Medicare tens of billions of dollars, study suggests On average, drugs commonly used by Medicare beneficiaries cost over four times more in the US than in the UK  The same drug may be anywhere from 30 percent to 7,000 percent… Read More »

Roche drops Alzheimher drug trials after setback

FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche Holding will halt two late-stage clinical trials of its crenezumab drug in early Alzheimer’s disease after an interim analysis indicated it was unlikely to hits its primary goal, the… Read More »